U.S. Gastro Update eNewsletter
July 2021

Study Explores Efficacy & Safety of OTC Chronic Constipation Products
While cases of constipation are frequently treated with OTC products, the safety and efficacy are largely unknown. To investigate these aspects, a systematic review published in The American Journal of Gastroenterology was conducted to assess the various OTC products for constipation and to provide evidence-based recommendations. Read more.


Study Reveals Gut Microbiome May Impact Patients After Stroke
Results from a recent study indicate that for the first time that the gut microbiome impacts the severity of stroke and function impairment following stroke. In a publication in Cell Host & Microbe, Zhu et al used knowledge gleaned from previous studies that have demonstrated a correlation between circulating levels of the gut microbiota–derived metabolite trimethylamine-N-oxide (TMAO) and stroke
risk. Read more.

Incidence of Resistant Salmonella Strains Rising in the United States
Salmonella, which is a major cause of food-borne illness in the U.S., is often a self-limited illness. Findings from a recent CDC report published in Emerging Infectious Diseases, however, indicate that "antimicrobial resistant" strains are on the rise and pose a serious threat to public health. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App